Connect
MJA
MJA

Telehealth: an opportunity to increase access to early medical abortion for Australian women

Danielle Mazza, Seema Deb and Asvini Subasinghe
Med J Aust 2020; 213 (7): . || doi: 10.5694/mja2.50782
Published online: 21 September 2020

Telehealth offers an opportunity to address limited access to early medical abortion during COVID‐19 and beyond

Access to early medical abortion (EMA), using mifepristone followed by misoprostol to end an early pregnancy, remains a challenge in Australia, especially for women from vulnerable groups and those living in rural and regional areas.1 Low numbers of general practitioner providers, lack of peer networks to support the establishment and ongoing provision of EMA services, and stigma are real barriers as is a broader lack of knowledge regarding medical abortion among health professionals.2,3 Many women are also unaware of the availability of EMA and the current gestational limit of 63 days.4 They also face difficulties navigating the health system to find an EMA provider, particularly when they encounter conscientious objections.4,5 Women can also face other barriers such as needing to travel to access services, take time off work or find childcare, and many need to source financial support to meet the costs.5

  • Danielle Mazza
  • Seema Deb
  • Asvini Subasinghe

  • Monash University, Melbourne, VIC

Correspondence: danielle.mazza@monash.edu

Competing interests:

No relevant disclosures.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.